Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

[1]  H. Sandler,et al.  Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy , 2012, Radiation Oncology.

[2]  D. T. Arp,et al.  Urethra sparing - potential of combined Nickel-Titanium stent and intensity modulated radiation therapy in prostate cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  P. Maingon,et al.  70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. , 2011, International journal of radiation oncology, biology, physics.

[4]  J. Madden,et al.  Focal therapy for prostate cancer: pathologic basis , 2009, Current opinion in urology.

[5]  Wadih Arap,et al.  Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.

[6]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[7]  Jan J W Lagendijk,et al.  Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. , 2007, International journal of radiation oncology, biology, physics.

[8]  Timothy Solberg,et al.  Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[9]  Lei Dong,et al.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[10]  Shugo Suzuki,et al.  Pitfalls with MRI Evaluation of Prostate Cancer Detection , 2006, Urologia Internationalis.

[11]  John T. Wei,et al.  Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. , 2006, International journal of radiation oncology, biology, physics.

[12]  Joos V Lebesque,et al.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Montie,et al.  Functional anatomy of the prostate: implications for treatment planning. , 2005, International journal of radiation oncology, biology, physics.

[14]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[15]  Marc L Kessler,et al.  Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate. , 2005, Medical physics.

[16]  C. Reddy,et al.  Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy , 2003 .

[17]  K. Wallner,et al.  Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. , 2003, The Journal of urology.

[18]  C. Reddy,et al.  Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  John T. Wei,et al.  Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Grise,et al.  Urinary incontinence following treatment of localized prostate cancer. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[21]  H M Sandler,et al.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.

[22]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[23]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[24]  Liying Zhang,et al.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Guilherme Godoy,et al.  Focal therapy: a new paradigm for the treatment of prostate cancer. , 2009, Reviews in urology.

[26]  C. Lawton,et al.  Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer , 2009 .

[27]  Butler Wm,et al.  Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905. , 2006 .

[28]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .